Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves’ disease: a single-center experience

Endocrine

Volumn 47, Issue 2, 2014, Pages 506-511

  Uchida, Toyoyoshi ^a   Goto, Hiromasa ^a   Kasai, Takatoshi ^b   Komiya, Koji ^a   Takeno, Kageumi ^a   Abe, Hiroko ^a   Shigihara, Nayumi ^a   Sato, Junko ^a   Honda, Akira ^a   Mita, Tomoya ^a   Kanazawa, Akio ^a   Fujitani, Yoshio ^a   Watada, Hirotaka ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Graves disease; Methimazole; Organic iodine; Retrospective study; Thyrotoxicosis

Indexed keywords

LIOTHYRONINE; POTASSIUM IODIDE; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; ANTITHYROID AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GRAVES DISEASE; GROUPS BY AGE; HUMAN; MALE; RASH; RETROSPECTIVE STUDY; THYROID FUNCTION; TREATMENT DURATION; YOUNG ADULT; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; MIDDLE AGED; POTASSIUM IODIDE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84911007886     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0171-8     Document Type: Article

References (26)

1. D.S. Cooper, Antithyroid drugs. N. Engl. J. Med. 352, 905–917 (2005)
2. S.M. McLachlan, Y. Nagayama, B. Rapoport, Insight into Graves’ hyperthyroidism from animal models. Endocr. Rev. 26, 800–832 (2005)
3. T.H. Totterman, F.A. Karlsson, M. Bengtsson, I. Mendel-Hartvig, Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves’ disease. N. Engl. J. Med. 316, 15–22 (1987)
4. N. Mitsiades, V. Poulaki, S. Tseleni-Balafouta, G.P. Chrousos, D.A. Koutras, Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves’ disease. Thyroid 10, 527–532 (2000)
5. M. Meyer-Gessner, G. Benker, T. Olbricht, R. Windeck, K. Cissewski, C. Reiners, D. Reinwein, Side effects of antithyroid therapy of hyperthyroidism. A study of 1256 continuously treated patients. Dtsch. Med. Wochenschr. 114, 166–171 (1989)
6. Y.F. Liaw, M.J. Huang, K.D. Fan, K.L. Li, S.S. Wu, T.J. Chen, Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern. Med. 118, 424–428 (1993)
7. L. Wartofsky, B.J. Ransil, S.H. Ingbar, Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J. Clin. Invest. 49, 78–86 (1970)
8. P.H. Eng, G.R. Cardona, S.L. Fang, Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140, 3404–3410 (1999)
9. L.J. Degroot, M.A. Greer, The effect of stable iodide on thyroid secretion in man. Metabolism 5, 682–696 (1956)
10. J. Wolff, I.L. Chaikoff, Plasma inorganic iodide as a homeostatic regulator of thyroid function. J. Biol. Chem. 174, 555–564 (1948)
11. S. Nagataki, K. Shizume, K. Nakao, Effect of iodide on thyroidal iodine turnover in hyperthyroid subjects. J. Clin. Endocrinol. Metab. 30, 469–478 (1970)
12. C.H. Emerson, A.J. Anderson, W.J. Howard, R.D. Utiger, Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J. Clin. Endocrinol. Metab. 40, 33–36 (1975)
13. G. Robuschi, A. Manfredi, M. Salvi, E. Gardini, M. Montermini, L. d’Amato, E. Borciani, L. Negrotti, A. Gnudi, E. Roti, Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves’ disease. J. Endocrinol. Invest. 9, 287–291 (1986)
14. G. Philippou, D.A. Koutras, G. Piperingos, A. Souvatzoglou, S.D. Moulopoulos, The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin. Endocrinol. (Oxf.) 36, 573–578 (1992)
15. C.M. Feek, J.S. Sawers, W.J. Irvine, G.J. Beckett, W.A. Ratcliffe, A.D. Toft, Combination of potassium iodide and propranolol in preparation of patients with Graves’ disease for thyroid surgery. N. Engl. J. Med. 302, 883–885 (1980)
16. E. Roti, G. Robuschi, E. Gardini, M. Montermini, M. Salvi, A. Manfredi, A. Gnudi, L.E. Braverman, Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves’ disease. Clin Endocrinol. (Oxf.) 28, 305–314 (1988)
17. K. Takata, N. Amino, S. Kubota, I. Sasaki, E. Nishihara, T. Kudo, M. Ito, S. Fukata, A. Miyauchi, Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves’ disease. Clin. Endocrinol. (Oxf.) 72, 845–850 (2010)
18. E. Roti, E. Gardini, R. Minelli, L. Bianconi, M. Salvi, G. Gavaruzzi, L.E. Braverman, Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves’ hyperthyroidism. J. Clin. Endocrinol. Metab. 76, 928–932 (1993)
19. E. Roti, G. Robuschi, A. Manfredi, L. D’Amato, E. Gardini, M. Salvi, M. Montermini, A.L. Barlli, A. Gnudi, L.E. Braverman, Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves’ disease. Clin. Endocrinol. (Oxf.) 22, 489–496 (1985)
20. T.T. Tan, P. Morat, M.L. Ng, B.A. Khalid, Effects of Lugol’s solution on thyroid function in normals and patients with untreated thyrotoxicosis. Clin. Endocrinol. (Oxf.) 30, 645–649 (1989)
21. G. Philippou, G. Piperingos, A. Souvatzoglou, D.A. Koutras, S.D. Moulopoulos, Treatment of hyperthyroidism with potassium iodide. Exp. Clin. Endocrinol. 97, 308–311 (1991)
22. T. Uchida, K. Takeno, M. Goto, R. Kanno, S. Kubo, S. Takahashi, K. Azuma, K. Sakai, Y. Fujitani, T. Hirose, R. Kawamori, H. Watada, Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patients. Endocr. J. 57, 439–443 (2010)
23. P.C. Austin, Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat. Med. 28, 3083–3107 (2009)
24. T. Kasai, K. Miyauchi, N. Kubota, K. Kajimoto, A. Amano, H. Daida, Probucol therapy improves long-term (>10-year) survival after complete revascularization: a propensity analysis. Atherosclerosis 220, 463–469 (2012)
25. T.T. Zava, D.T. Zava, Assessment of Japanese iodine intake based on seaweed consumption in Japan: a literature-based analysis. Thyroid Res. 4, 14 (2011)
26. B.R. Shah, A. Laupacis, J.E. Hux, P.C. Austin, Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J. Clin. Epidemiol. 58, 550–559 (2005)